Prosecution Insights
Prosecution Insights
11 pending office actions • 11 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (9%) |
| §103 only | 4 (36%) |
| Multi-statute (no §101) | 6 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HO, ANH N | 1 | 82.4% | +13.8% |
| REICHERT, RACHELLE LEIGH | 1 | 30.0% | +33.7% |
| PROSSER, ALISSA J | 1 | 15.8% | +11.3% |
| ROTONDI, CONNOR JON | 1 | 0.0% | +0.0% |
| FOLEY, SHANON A | 1 | 73.2% | +18.0% |
| MOORE, WHITNEY | 1 | 88.1% | +10.0% |
| KIM, BRYAN | 1 | 28.5% | +36.9% |
| DORNA, CARRIE R | 1 | 72.2% | +27.9% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.1% |
| MARTIN, KEVIN STEPHEN | 1 | 75.8% | +24.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17886881 | THREE-DIMENSIONAL (3D) HERNIA PLUG DEVICE AND A METHOD OF MANUFACTURING THEREOF | DORNA, CARRIE R | 43d overdue |
| 18546637 | PULSE PROTEIN GELATION | KIM, BRYAN | 8d |
| 18290853 | METHOD OF SLUDGE PRETREATMENT FOR IMPROVED DIGESTIBILITY AND REDUCED SCALING | ROTONDI, CONNOR JON | 15d |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 53d |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | — |
| 18506083 | SEMICONDUCTOR SYSTEM WITH WAVEGUIDE ASSEMBLY WITH RF SIGNAL IMPREDANCE CONTROLLABLE BY APPLIED ELECTROMAGNETIC RADIATION | MOORE, WHITNEY | — |
| 17596491 | TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF | MARTIN, KEVIN STEPHEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17886881 | THREE-DIMENSIONAL (3D) HERNIA PLUG DEVICE AND A METHOD OF MANUFACTURING THEREOF | DORNA, CARRIE R | 43d overdue |
| 18546637 | PULSE PROTEIN GELATION | KIM, BRYAN | 8d |
| 17725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | DONOHUE, SEAN R | 29d |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 53d |
| 19217642 | ANTENNA USING EMBEDDED MTM-EBG UNIT CELLS | HO, ANH N | — |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | — |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | FOLEY, SHANON A | — |
| 18506083 | SEMICONDUCTOR SYSTEM WITH WAVEGUIDE ASSEMBLY WITH RF SIGNAL IMPREDANCE CONTROLLABLE BY APPLIED ELECTROMAGNETIC RADIATION | MOORE, WHITNEY | — |
| Art Unit | Apps |
|---|---|
| 2845 | 1 |
| 3686 | 1 |
| 1619 | 1 |
| 1779 | 1 |
| 1671 | 1 |
| 3646 | 1 |
| 1792 | 1 |
| 3791 | 1 |
| 1618 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19217642 | ANTENNA USING EMBEDDED MTM-EBG UNIT CELLS | HO, ANH N | 2845 | §103 | Non-Final OA | — | Pending | May 23, 2025 |
| 18837460 | SYSTEMS AND DEVICES FOR COUPLING METABOLOMICS DATA WITH DIGITAL MONITORS FOR PRECISION HEALTH | REICHERT, RACHELLE LEIGH | 3686 | §101§102§112 | Final Rejection | — | Pending | Aug 09, 2024 |
| 18691738 | SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER | PROSSER, ALISSA J | 1619 | §103§112 | Non-Final OA | 53d | Pending | Mar 13, 2024 |
| 18290853 | METHOD OF SLUDGE PRETREATMENT FOR IMPROVED DIGESTIBILITY AND REDUCED SCALING | ROTONDI, CONNOR JON | 1779 | §103§112 | Non-Final OA | 15d | Pending | Jan 22, 2024 |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | FOLEY, SHANON A | 1671 | §103 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18506083 | SEMICONDUCTOR SYSTEM WITH WAVEGUIDE ASSEMBLY WITH RF SIGNAL IMPREDANCE CONTROLLABLE BY APPLIED ELECTROMAGNETIC RADIATION | MOORE, WHITNEY | 3646 | §102§103Other | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18546637 | PULSE PROTEIN GELATION | KIM, BRYAN | 1792 | §102§103§112 | Non-Final OA | 8d | Pending | Aug 30, 2023 |
| 17886881 | THREE-DIMENSIONAL (3D) HERNIA PLUG DEVICE AND A METHOD OF MANUFACTURING THEREOF | DORNA, CARRIE R | 3791 | §102§103 | Final Rejection | 43d overdue | Pending | Aug 12, 2022 |
| 17725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 29d | Pending | Apr 20, 2022 |
| 17596491 | TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF | MARTIN, KEVIN STEPHEN | 1624 | §102§112 | Final Rejection | — | Pending | Dec 10, 2021 |
| 17599282 | XYLOGLUCAN-CONTAINING PRODRUGS AND METHODS OF MANUFACTURE AND USE THEREOF | HIBSHMAN, SARAH GRACE | 1693 | §103 | Non-Final OA | — | Pending | Sep 28, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial